Veradigm | Le Coût Des Ventes



Cost Of Sales Changement Date
Alcidion AUD 1.41M 912K 2024-06
Ambu A/S DKK 585M 15M 2024-12
Amplifon EUR -296774000 748.41M 2024-12
Cardinal Health USD 53.32B 2.95B 2024-12
Centene USD 37.08B 903M 2024-12
Charles River Laboratories USD 682.87M 40.87M 2024-12
Cigna USD 59.19B 2.1B 2024-12
Convatec Group 515.3M 270.15M 2024-12
CVS Health USD 84.81B 1.94B 2024-12
Diasorin EUR 99M 3.27M 2024-09
Elevance Health 33.5B 551M 2024-12
General Electric USD 6.2B 977M 2025-03
Gulf Medical Proj AED 133.62M 13.35M 2024-12
Humana 25.38B 24.75B 2024-12
IQVIA Holdings USD 2.58B 62M 2024-12
Kora Saude BRL 443.07M 18.22M 2024-12
Laboratory Of America USD 2.43B 55.5M 2024-12
Maximus USD 1.1B 86.94M 2024-12
McKesson USD 92.04B 1.64B 2024-12
Med Life RON 181.35M 7.32M 2024-09
Molina Healthcare USD 9.48B 476M 2025-03
Omnicell USD 163.95M 4.44M 2024-12
Oriola-kd EUR 398.1M 11.5M 2024-12
Owens Minor USD 2.12B 45.11M 2024-12
Quest Diagnostics USD 1.79B 26M 2025-03
Rede D'or Sao Luiz BRL 10.45B 130.01M 2024-12
Siemens Healthineers EUR 3.33B 591M 2024-12
Sonova Holding CHF 514.8M 7M 2024-09
UnitedHealth 79.5B 1.71B 2024-12
Veeva Systems USD 180.99M 6.6M 2025-01
Walgreens Boots Alliance USD 31.65B 1.03B 2025-02
Xerox USD 1.11B 78M 2024-12



Veradigm Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.